Role of imaging in predicting response to neoadjuvant chemotherapy in gastric cancer.
With the proven overall benefit of neoadjuvant chemotherapy in patients with locally advanced gastric cancer, there has come a need to discriminate responders from non-responders. In this article, the current role of anatomical and molecular imaging in the prediction of response to neoadjuvant therapy in gastric cancer is outlined and future prospects are discussed.
['Kwee|Robert Michael|RM|', 'Kwee|Thomas Christian|TC|']
D000971:Antineoplastic Combined Chemotherapy Protocols D017024:Chemotherapy, Adjuvant D038524:Diffusion Magnetic Resonance Imaging D019788:Fluorodeoxyglucose F18 D006801:Humans D008279:Magnetic Resonance Imaging D057054:Molecular Imaging D020360:Neoadjuvant Therapy D049268:Positron-Emission Tomography D013274:Stomach Neoplasms D016896:Treatment Outcome
Imaging Response Chemotherapy Gastric cancer Neoadjuvant therapy